The enzyme myristoyl-CoA:protein N-myristoyltransferase (NMT, EC 2.3.1.97) has been extensively investigated as a drug target in human cancer [11]–[13], and in infectious diseases caused by viruses [13]–[15], pathogenic fungi [16], and parasitic protozoa including Trypanosoma brucei[17]–[19], Trypanosoma cruzi[20], Leishmania major[18], Leishmania donovani[21], and Plasmodium falciparum[17], [18], [22]. The gene discussed is NMT1; the disease is cancer.